Biotech Showcase 2015 EBD Group Demy Colton Life Science Advisors Biotech Showcase 2015
Share:
Email this page Share this on LinkedIn Share this on Twitter

Biotech Showcase™ 2015 Press Releases

News for Biotech Showcase™ 2015 will be available soon

Biotech Showcase 2014 press releases

January 23, 2014Unprecedented Biotech Showcase™ 2014 attendance reflects investor appetite for biotech innovationOver 1,700 delegates attend investor conference in San Francisco
The sixth annual Biotech Showcase investor conference wrapped up last week in San Francisco with record attendance. The event, every January at Parc 55 Wyndham San Francisco - Union Square, is an investment weathervane for the biotech industry. "There was clearly significant momentum behind the conference this year. The event benefited from the up market for life sciences c...  more ►

January 9, 2014Biotech Investing Strategies in 2014 is key topic bringing investors to San Francisco for Biotech Showcase™ 2014 next week, January 13 Innovative presenting companies comprising early stage and biotech are on the program for the sixth annual Biotech Showcase investor and partnering conference taking place in San Francisco next week. The event, held January 13–15 at Parc 55 Wyndham San Francisco - Union Square, already has 963 companies and 1,480 delegates attending, providing a forum for investors to ca...  more ►

December 18, 2013Biotech Showcase™ program speakers have their fingers on the pulse of biotech Biotech Showcase investor and partnering conference returns to San Francisco for the sixth year. This established innovation showcase for life science investors will be held January 13–15, 2014 at Parc 55 Wyndham San Francisco - Union Square. The event draws executives representing top public and private biotech and life science companies and investors seeking new opport...  more ►

November 21, 2013Sixth Annual Biotech Showcase™ returns to San Francisco January 13–15Event is annual investing and partnering benchmark for life science executives and investors
The sixth annual Biotech Showcase investor and partnering conference will be held January 13–15, 2014 in San Francisco, CA at Parc 55 Wyndham San Francisco - Union Square. The event is an established innovation showcase for life science investors. Executive-level delegates representing top public and private investment firms come with the single aim to partner with emerg...  more ►



partnering360:Insight Latest headlines from partnering360:Insight

August 13, 2014 Gene, stem cell therapies bring new players to partnering The next generation of therapies built upon the science of stem cells and genetics will require new types of partnerships. If there is promise that these technologies can redefine how we understand and treat disease, there is already a certainty that the alliances and partnerships required to bring these therapies to patients are also beyond traditional models for commercialization. more ►

August 1, 2014 J&J: “Innovation delivers growth and growth sustains our innovation” "What we are really trying to accomplish is building more than a financial relationship. We are interested in truly finding a way to get to the outcomes. We want to keep our partners intimately involved in a pursuit of truth, in understanding what this science means in the lives of patients who might benefit the most from it. It is this dialogue we are after." more ►

July 28, 2014 Deal trends in Regenerative Medicine The field of regenerative medicine is an up-and-coming new approach for targeting and treating diseases, involving the repair and restoration of previously damaged tissues or organs in the body. According to the Current Agreements life science deals and alliance database, there have been over 700 regenerative medicine/stem cell deals in the last five years alone. more ►

July 22, 2014 Promethera expands portfolio with progenitor cell platform Eric Halioua arrives at BioPharm America™ in Boston this September carrying an expanding portfolio of partnering opportunities based on a platform of human liver progenitor cells. more ►

July 22, 2014 CoStim Pharma: People plus hot science create stunning combo-combo deal Pathways and platforms are great but true exits come around product portfolios, says Robert Millman, a founder and the chief executive for CoStim Pharmaceuticals, which was snapped up by Novartis just 10 months after the company's first funding round. more ►



Arrow Up


 
 
See more upcoming conferences ►

EBD Group's Family of Events

© 2009–2014 EBD Group, Inc.
Privacy Policy
Terms of Use
Biotech Showcase 2015 EBD Group Demy Colton Life Science Advisors Biotech Showcase 2015